Venrock Healthcare Capital Partners Ii, L.p. - Net Worth and Insider Trading

Venrock Healthcare Capital Partners Ii, L.p. Net Worth

The estimated net worth of Venrock Healthcare Capital Partners Ii, L.p. is at least $20 Million dollars as of 2024-04-26. Venrock Healthcare Capital Partners Ii, L.p. is the 10% Owner of KalVista Pharmaceuticals Inc and owns about 1,544,112 shares of KalVista Pharmaceuticals Inc (KALV) stock worth over $17 Million. Venrock Healthcare Capital Partners Ii, L.p. is the 10% Owner of Vistagen Therapeutics Inc and owns about 687,909 shares of Vistagen Therapeutics Inc (VTGN) stock worth over $3 Million. Venrock Healthcare Capital Partners Ii, L.p. is also the 10% Owner of Tricida Inc and owns about 3,751,406 shares of Tricida Inc (TCDAQ) stock worth over $38. Details can be seen in Venrock Healthcare Capital Partners Ii, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Venrock Healthcare Capital Partners Ii, L.p. has not made any transactions after 2022-10-26 and currently still holds the listed stock(s).

Transaction Summary of Venrock Healthcare Capital Partners Ii, L.p.

To

Venrock Healthcare Capital Partners Ii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Venrock Healthcare Capital Partners Ii, L.p. owns 10 companies in total, including Cogent Biosciences Inc (COGT) , Altimmune Inc (ALT) , and Constellation Pharmaceuticals Inc (CNST) among others .

Click here to see the complete history of Venrock Healthcare Capital Partners Ii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Venrock Healthcare Capital Partners Ii, L.p.

Ticker Comapny Transaction Date Type of Owner
COGT Cogent Biosciences Inc 2020-08-13 10 percent owner
ALT Altimmune Inc 2021-02-25 10 percent owner
CNST Constellation Pharmaceuticals Inc 2019-12-13 10 percent owner
BLPH Bellerophon Therapeutics Inc 2018-08-13 10 percent owner
KALV KalVista Pharmaceuticals Inc 2019-03-18 10 percent owner
SWAV Shockwave Medical Inc 2019-03-06 10 percent owner
ABIO ARCA biopharma Inc 2015-06-16 10 percent owner
ADVM Adverum Biotechnologies Inc 2014-08-05 10 percent owner
TCDAQ Tricida Inc 2022-10-26 10 percent owner
VTGN Vistagen Therapeutics Inc 2022-07-12 10 percent owner

Venrock Healthcare Capital Partners Ii, L.p. Latest Holdings Summary

Venrock Healthcare Capital Partners Ii, L.p. currently owns a total of 3 stocks. Among these stocks, Venrock Healthcare Capital Partners Ii, L.p. owns 1,544,112 shares of KalVista Pharmaceuticals Inc (KALV) as of March 18, 2019, with a value of $17 Million and a weighting of 83.59%. Venrock Healthcare Capital Partners Ii, L.p. owns 687,909 shares of Vistagen Therapeutics Inc (VTGN) as of July 12, 2022, with a value of $3 Million and a weighting of 16.41%. Venrock Healthcare Capital Partners Ii, L.p. also owns 3,751,406 shares of Tricida Inc (TCDAQ) as of October 26, 2022, with a value of $38 and a weighting of 0%.

Latest Holdings of Venrock Healthcare Capital Partners Ii, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KALV KalVista Pharmaceuticals Inc 2019-03-18 1,544,112 10.78 16,645,527
VTGN Vistagen Therapeutics Inc 2022-07-12 687,909 4.75 3,267,568
TCDAQ Tricida Inc 2022-10-26 3,751,406 0.00 38

Holding Weightings of Venrock Healthcare Capital Partners Ii, L.p.


Venrock Healthcare Capital Partners Ii, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Venrock Healthcare Capital Partners Ii, L.p. has made a total of 0 transactions in KalVista Pharmaceuticals Inc (KALV) over the past 5 years. The most-recent trade in KalVista Pharmaceuticals Inc is the sale of 500,000 shares on March 18, 2019, which brought Venrock Healthcare Capital Partners Ii, L.p. around $14 Million.

According to the SEC Form 4 filings, Venrock Healthcare Capital Partners Ii, L.p. has made a total of 1 transactions in Vistagen Therapeutics Inc (VTGN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Vistagen Therapeutics Inc is the sale of 2,000 shares on July 12, 2022, which brought Venrock Healthcare Capital Partners Ii, L.p. around $53,400.

According to the SEC Form 4 filings, Venrock Healthcare Capital Partners Ii, L.p. has made a total of 20 transactions in Tricida Inc (TCDAQ) over the past 5 years, including 19 buys and 1 sells. The most-recent trade in Tricida Inc is the sale of 6,451,540 shares on October 26, 2022, which brought Venrock Healthcare Capital Partners Ii, L.p. around $3 Million.

Insider Trading History of Venrock Healthcare Capital Partners Ii, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Venrock Healthcare Capital Partners Ii, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Venrock Healthcare Capital Partners Ii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Venrock Healthcare Capital Partners Ii, L.p. is -44.82%. GuruFocus also compares Venrock Healthcare Capital Partners Ii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Venrock Healthcare Capital Partners Ii, L.p. within 3 months outperforms 8 times out of 19 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Venrock Healthcare Capital Partners Ii, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Venrock Healthcare Capital Partners Ii, L.p.

Average Return

-99.94%

Average return per transaction

Outperforming Transactions

0%

0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -20.72 -44.82 -99.06 -99.94
Relative Return to S&P 500(%) -23.44 -45.2 -103.12 -112

Venrock Healthcare Capital Partners Ii, L.p. Ownership Network

Ownership Network List of Venrock Healthcare Capital Partners Ii, L.p.

No Data

Ownership Network Relation of Venrock Healthcare Capital Partners Ii, L.p.


Venrock Healthcare Capital Partners Ii, L.p. Owned Company Details

What does Cogent Biosciences Inc do?

Who are the key executives at Cogent Biosciences Inc?

Venrock Healthcare Capital Partners Ii, L.p. is the 10 percent owner of Cogent Biosciences Inc. Other key executives at Cogent Biosciences Inc include 10 percent owner & other: See Remarks Fairmount Funds Management Llc , Chief Legal Officer Evan Kearns , and Chief Financial Officer John L. Green .

Cogent Biosciences Inc (COGT) Insider Trades Summary

Over the past 18 months, Venrock Healthcare Capital Partners Ii, L.p. made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cogent Biosciences Inc Insider Transactions

No Available Data

Venrock Healthcare Capital Partners Ii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Venrock Healthcare Capital Partners Ii, L.p.. You might contact Venrock Healthcare Capital Partners Ii, L.p. via mailing address: 7 Bryant Park, 23rd Floor, New York Ny 10018.

Discussions on Venrock Healthcare Capital Partners Ii, L.p.

No discussions yet.